
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="CFBE20DE930A48D30020DE00E13BB241.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jamasd">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="JAMA Network Open">
<meta name="citation_title" content="Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial">
<meta name="citation_author" content="Shen He">
<meta name="citation_author_institution" content="Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China">
<meta name="citation_author" content="Jing-Xu Chen">
<meta name="citation_author_institution" content="Sleep Medicine Center, Beijing Huilongguan Hospital, Beijing, China">
<meta name="citation_author" content="XueQin Yu">
<meta name="citation_author_institution" content="Chongqing Mental Health Center, Chongqing, China">
<meta name="citation_author" content="Huali Lin">
<meta name="citation_author_institution" content="Xi’an Mental Health Center, Xi’an, China">
<meta name="citation_author" content="ZhiQiang Wang">
<meta name="citation_author_institution" content="Wuxi Mental Health Center, Wuxi, Jiangsu, China">
<meta name="citation_author" content="Xuan Li">
<meta name="citation_author_institution" content="Guangzhou Medical University Affiliated Brain Hospital, Guangzhou, Guangdong, China">
<meta name="citation_author" content="Yanan Zhou">
<meta name="citation_author_institution" content="Department of Psychiatry, The Second Xiangya Hospital, Central South; University, Changsha, Hunan, China">
<meta name="citation_author" content="Yan-Song Liu">
<meta name="citation_author_institution" content="Department of Clinical Psychology, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu, China">
<meta name="citation_author" content="Hongyan Zhang">
<meta name="citation_author_institution" content="Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, Peking University, Beijing, China">
<meta name="citation_author_institution" content="National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, Beijing, China">
<meta name="citation_author" content="Jicai Wang">
<meta name="citation_author_institution" content="Department of Clinical Psychology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China">
<meta name="citation_author" content="Cuixia An">
<meta name="citation_author_institution" content="Department of Clinical Psychology, First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China">
<meta name="citation_author" content="Hao Liu">
<meta name="citation_author_institution" content="Department of Clinical Psychology, Wuhan University People’s Hospital, Wuhan, China">
<meta name="citation_author" content="Chao Li">
<meta name="citation_author_institution" content="CSPC Pharmaceutical Group Co Ltd, Shijiazhuang, Hebei, China">
<meta name="citation_author" content="Shaonan Ni">
<meta name="citation_author_institution" content="CSPC Pharmaceutical Group Co Ltd, Shijiazhuang, Hebei, China">
<meta name="citation_author" content="Huafang Li">
<meta name="citation_author_institution" content="Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China">
<meta name="citation_publication_date" content="2025 Sep 22">
<meta name="citation_volume" content="8">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e2532650">
<meta name="citation_doi" content="10.1001/jamanetworkopen.2025.32650">
<meta name="citation_pmid" content="40982284">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/">
<meta name="description" content="Is ammoxetine safe and effective for treating major depressive disorder (MDD)? In this randomized clinical trial in 239 adult patients with MDD, both ammoxetine 40 mg/d and 60 mg/d significantly decreased the total score of the Montgomery-Åsberg ...">
<meta name="og:title" content="Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Is ammoxetine safe and effective for treating major depressive disorder (MDD)? In this randomized clinical trial in 239 adult patients with MDD, both ammoxetine 40 mg/d and 60 mg/d significantly decreased the total score of the Montgomery-Åsberg ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12455369">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1001/jamanetworkopen.2025.32650"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12455369%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12455369/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12455369/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jamasd.png" alt="JAMA Network logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to JAMA Network" title="Link to JAMA Network" shape="default" href="https://doi.org/10.1001/jamanetworkopen.2025.32650" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">JAMA Netw Open</button></div>. 2025 Sep 22;8(9):e2532650. doi: <a href="https://doi.org/10.1001/jamanetworkopen.2025.32650" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1001/jamanetworkopen.2025.32650</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22JAMA%20Netw%20Open%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22JAMA%20Netw%20Open%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JAMA%20Netw%20Open%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22JAMA%20Netw%20Open%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Efficacy and Safety of Ammoxetine in Major Depressive Disorder</h1>
<p>A Randomized Clinical Trial</p></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shen He</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Shen He</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shen He</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20JX%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jing-Xu Chen</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Jing-Xu Chen</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>2</sup>Sleep Medicine Center, Beijing Huilongguan Hospital, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20JX%22%5BAuthor%5D" class="usa-link"><span class="name western">Jing-Xu Chen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">XueQin Yu</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">XueQin Yu</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>3</sup>Chongqing Mental Health Center, Chongqing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">XueQin Yu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Huali Lin</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Huali Lin</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>4</sup>Xi’an Mental Health Center, Xi’an, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huali Lin</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">ZhiQiang Wang</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">ZhiQiang Wang</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>5</sup>Wuxi Mental Health Center, Wuxi, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">ZhiQiang Wang</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Xuan Li</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Xuan Li</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>6</sup>Guangzhou Medical University Affiliated Brain Hospital, Guangzhou, Guangdong, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xuan Li</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yanan Zhou</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Yanan Zhou</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>7</sup>Department of Psychiatry, The Second Xiangya Hospital, Central South; University, Changsha, Hunan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanan Zhou</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20YS%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Yan-Song Liu</span></a><div hidden="hidden" id="id8">
<h3>
<span class="name western">Yan-Song Liu</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>8</sup>Department of Clinical Psychology, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20YS%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan-Song Liu</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Hongyan Zhang</span></a><div hidden="hidden" id="id9">
<h3>
<span class="name western">Hongyan Zhang</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>9</sup>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, Peking University, Beijing, China</div>
<div class="p">
<sup>10</sup>National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hongyan Zhang</span></a>
</div>
</div>
<sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Jicai Wang</span></a><div hidden="hidden" id="id10">
<h3>
<span class="name western">Jicai Wang</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>11</sup>Department of Clinical Psychology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jicai Wang</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22An%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Cuixia An</span></a><div hidden="hidden" id="id11">
<h3>
<span class="name western">Cuixia An</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>12</sup>Department of Clinical Psychology, First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22An%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cuixia An</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Hao Liu</span></a><div hidden="hidden" id="id12">
<h3>
<span class="name western">Hao Liu</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>13</sup>Department of Clinical Psychology, Wuhan University People’s Hospital, Wuhan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hao Liu</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Chao Li</span></a><div hidden="hidden" id="id13">
<h3>
<span class="name western">Chao Li</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>14</sup>CSPC Pharmaceutical Group Co Ltd, Shijiazhuang, Hebei, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chao Li</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ni%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Shaonan Ni</span></a><div hidden="hidden" id="id14">
<h3>
<span class="name western">Shaonan Ni</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>14</sup>CSPC Pharmaceutical Group Co Ltd, Shijiazhuang, Hebei, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ni%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shaonan Ni</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Huafang Li</span></a><div hidden="hidden" id="id15">
<h3>
<span class="name western">Huafang Li</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div class="p">
<sup>15</sup>Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huafang Li</span></a>
</div>
</div>
<sup>1,</sup><sup>15,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="zoi250921aff1">
<sup>1</sup>Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China</div>
<div id="zoi250921aff2">
<sup>2</sup>Sleep Medicine Center, Beijing Huilongguan Hospital, Beijing, China</div>
<div id="zoi250921aff3">
<sup>3</sup>Chongqing Mental Health Center, Chongqing, China</div>
<div id="zoi250921aff4">
<sup>4</sup>Xi’an Mental Health Center, Xi’an, China</div>
<div id="zoi250921aff5">
<sup>5</sup>Wuxi Mental Health Center, Wuxi, Jiangsu, China</div>
<div id="zoi250921aff6">
<sup>6</sup>Guangzhou Medical University Affiliated Brain Hospital, Guangzhou, Guangdong, China</div>
<div id="zoi250921aff7">
<sup>7</sup>Department of Psychiatry, The Second Xiangya Hospital, Central South; University, Changsha, Hunan, China</div>
<div id="zoi250921aff8">
<sup>8</sup>Department of Clinical Psychology, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu, China</div>
<div id="zoi250921aff9">
<sup>9</sup>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health, Peking University, Beijing, China</div>
<div id="zoi250921aff10">
<sup>10</sup>National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital, Beijing, China</div>
<div id="zoi250921aff11">
<sup>11</sup>Department of Clinical Psychology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China</div>
<div id="zoi250921aff12">
<sup>12</sup>Department of Clinical Psychology, First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China</div>
<div id="zoi250921aff13">
<sup>13</sup>Department of Clinical Psychology, Wuhan University People’s Hospital, Wuhan, China</div>
<div id="zoi250921aff14">
<sup>14</sup>CSPC Pharmaceutical Group Co Ltd, Shijiazhuang, Hebei, China</div>
<div id="zoi250921aff15">
<sup>15</sup>Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China</div>
<div class="author-notes p">
<div class="fn" id="p1">
<p><strong>Accepted for Publication:</strong> July 14, 2025.</p>
<p><strong>Published:</strong> September 22, 2025. doi:<a href="https://doi.org/10.1001/jamanetworkopen.2025.32650" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1001/jamanetworkopen.2025.32650</a></p>
<p><strong>Open Access:</strong> This is an open access article distributed under the terms of the <a href="https://jamanetwork.com/pages/cc-by-nc-nd-license-permissions" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CC-BY-NC-ND License</a>, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies. © 2025 He S et al. <em>JAMA Network Open</em>.</p>
</div>
<div class="fn" id="zoi250921cor1">
<sup>✉</sup><p class="display-inline"><strong>Corresponding Author:</strong> Huafang Li, MD, Department of Psychiatry, Shanghai Mental Health Center, No. 600 Wan Ping S Rd, Shanghai 200030, China (<span>lihuafang@smhc.org.cn</span>).</p>
</div>
<div class="fn" id="p4">
<p><strong>Author Contributions:</strong> Dr H. Li had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
<p><em>Concept and design:</em> Zhang, An, H. Liu, C. Li, Ni, H. Li.</p>
<p><em>Acquisition, analysis, or interpretation of data:</em> He, Chen, Yu, Lin, Z. Wang, X. Li, Zhou, Y. Liu, J. Wang, An, Ni, H. Li.</p>
<p><em>Drafting of the manuscript:</em> He, Z. Wang, Zhou, Y. Liu.</p>
<p><em>Critical review of the manuscript for important intellectual content:</em> Chen, Yu, Lin, X. Li, Zhang, J. Wang, An, H. Liu, C. Li, Ni, H. Li.</p>
<p><em>Statistical analysis:</em> X. Li, An, Ni.</p>
<p><em>Administrative, technical, or material support:</em> He, Chen, Yu, Lin, Z. Wang, Zhou, Y. Liu, J. Wang, H. Liu, C. Li, H. Li.</p>
<p><em>Supervision:</em> Zhang, C. Li, H. Li.</p>
<p><strong>Conflict of Interest Disclosures:</strong> None reported.</p>
<p><strong>Funding/Support:</strong> This study was sponsored by CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd.</p>
<p><strong>Role of the Funder/Sponsor:</strong> The sponsor designed the study and oversaw its conduct through monitoring, and the principal investigator and study sites independently executed the trial and collected data. The sponsor was involved in the study management; data analysis and interpretation; and manuscript preparation, review, and approval.</p>
<p><strong>Data Sharing Statement:</strong> See <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 3</a>.</p>
<p><strong>Additional Contributions:</strong> The authors acknowledge Chao Liu, MD, PhD, and Lei Wang, MM (employees of the sponsor CSPC Zhongqi Pharmaceutical Technology) for providing medical writing and editorial support. They were not compensated beyond their usual salary.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 27; Accepted 2025 Jul 14; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright 2025 He S et al. <em>JAMA Network Open</em>.</div>
<p>This is an open access article distributed under the terms of the CC-BY-NC-ND License, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12455369  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40982284/" class="usa-link">40982284</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Key Points</h2>
<section id="ab-zoi250921-1"><h3 class="pmc_sec_title">Question</h3>
<p>Is ammoxetine safe and effective for treating major depressive disorder (MDD)?</p></section><section id="ab-zoi250921-2"><h3 class="pmc_sec_title">Findings</h3>
<p>In this randomized clinical trial in 239 adult patients with MDD, both ammoxetine 40 mg/d and 60 mg/d significantly decreased the total score of the Montgomery-Åsberg Depression Rating Scale from baseline to week 8 compared with placebo. The incidence and nature of adverse events were similar among groups.</p></section><section id="ab-zoi250921-3"><h3 class="pmc_sec_title">Meaning</h3>
<p>These findings support the safety and efficacy of ammoxetine in the treatment of MDD, providing a basis for phase 3 validation.</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>This randomized clinical trial evaluates the efficacy and safety of ammoxetine 60 mg/d and 40 mg/d vs placebo in treating adult major depressive disorder.</p></section><section class="abstract" id="abstract3"><h2>Abstract</h2>
<section id="ab-zoi250921-4"><h3 class="pmc_sec_title">Importance</h3>
<p>Major depressive disorder (MDD) is among the most prevalent mental health disorders, causing substantial disability and economic burden. Although several first-line treatments exist with mild adverse effects, up to 50% to 60% of patients do not tolerate or respond to them. Ammoxetine, a novel selective serotonin and norepinephrine reuptake inhibitor, has been found to reduce adverse effects and hepatotoxicity and more potent inhibition of serotonin and norepinephrine transporters, making it more tolerable and effective.</p></section><section id="ab-zoi250921-5"><h3 class="pmc_sec_title">Objective</h3>
<p>To evaluate the efficacy and safety of ammoxetine in treating adults with MDD.</p></section><section id="ab-zoi250921-6"><h3 class="pmc_sec_title">Design, Setting, and Participants</h3>
<p>This phase 2 randomized clinical trial was a multicenter, double-masked, placebo-controlled, parallel-group, fixed-dose study of ammoxetine treatment in patients with MDD in China. Patients aged 18 to 65 years from 15 study centers were randomized into daily ammoxetine or placebo groups between March 27, 2023, and June 13, 2024, and followed up for 10 weeks.</p></section><section id="ab-zoi250921-7"><h3 class="pmc_sec_title">Interventions</h3>
<p>Participants were randomized 1:1:1 to 3 treatment groups: ammoxetine 40 mg/d, ammoxetine 60 mg/d, and placebo.</p></section><section id="ab-zoi250921-8"><h3 class="pmc_sec_title">Main Outcome and Measures</h3>
<p>The primary outcome was change in Montgomery-Åsberg Depression Rating Scale (MADRS) total score from baseline to 8 weeks. Efficacy analyses were performed on both the full-analysis and per-protocol sets using least-squares (LS) mean differences. The safety set analysis was performed using descriptive statistics.</p></section><section id="ab-zoi250921-9"><h3 class="pmc_sec_title">Results</h3>
<p>Among 239 enrolled patients (mean [SD] age, 30.4 [10.0] years, 158 female [66.1%]), 80 were randomized to the ammoxetine 60 mg/d group, 80 to the ammoxetine 40 mg/d group, and 79 to the placebo group. In the full-analysis set, both ammoxetine doses led to statistically significant improvements in MADRS total scores at week 8 compared with placebo. The LS mean changes (SE) from baseline were −16.7 (1.3) for ammoxetine 40 mg/d, −16.6 (1.3) for ammoxetine 60 mg/d, and −13.5 (1.3) for placebo. The differences vs placebo were −3.3 (97.3 CI, −6.3 to −0.3) for ammoxetine 40 mg/d and −3.1 (97.3% CI, −6.2 to 0.0) for ammoxetine 60 mg/d. Consistent results were observed in the per-protocol set analysis at week 8 for ammoxetine 40 mg/d (LS mean change, −3.2; 97.3% CI, −6.2 to −0.2) and ammoxetine 60 mg/d (LS mean change, −3.18; 97.3% CI, −6.2 to −0.2), both superior to placebo. Treatment-emergent adverse events were reported in 68 participants (85.0%) receiving ammoxetine 60 mg/d, 63 (78.8%) receiving ammoxetine 40 mg/d, and 48 (60.8%) receiving placebo; most were mild to moderate in severity.</p></section><section id="ab-zoi250921-10"><h3 class="pmc_sec_title">Conclusions and Relevance</h3>
<p>This randomized clinical trial demonstrated superiority over placebo of ammoxetine treatment at both 40 mg/d and 60 mg/d in patients with MDD. In addition, all doses of ammoxetine were generally well tolerated.</p></section><section id="ab-zoi250921-11"><h3 class="pmc_sec_title">Trial Registration</h3>
<p>ClinicalTrials.gov Identifier: <a href="https://clinicaltrials.gov/study/NCT05762458?term=NCT05762458&amp;rank=1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05762458</a></p></section></section><section id="H1-1-ZOI250921"><h2 class="pmc_sec_title">Introduction</h2>
<p>Major depressive disorder (MDD) is among the most prevalent mental health disorders, causing substantial disability and economic burden.<sup><a href="#zoi250921r1" class="usa-link" aria-describedby="zoi250921r1">1</a>,<a href="#zoi250921r2" class="usa-link" aria-describedby="zoi250921r2">2</a></sup> The World Health Organization reported that MDD will become the primary cause of disability worldwide by 2030.<sup><a href="#zoi250921r3" class="usa-link" aria-describedby="zoi250921r3">3</a></sup> Various classes of antidepressant medications include selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SNRIs), mirtazapine, tricyclic antidepressants, and monoamine oxidase inhibitors, among others.<sup><a href="#zoi250921r4" class="usa-link" aria-describedby="zoi250921r4">4</a></sup> Due to their relatively mild adverse effects, SSRIs and SNRIs are often recommended as first-line treatment for MDD.<sup><a href="#zoi250921r5" class="usa-link" aria-describedby="zoi250921r5">5</a></sup> However, 50% to 60% of patients cannot tolerate or do not respond adequately to them.<sup><a href="#zoi250921r6" class="usa-link" aria-describedby="zoi250921r6">6</a></sup> The STAR*D study indicated that only 30% to 40% of patients reached remission with first-line antidepressants.<sup><a href="#zoi250921r7" class="usa-link" aria-describedby="zoi250921r7">7</a></sup> Additionally, these medications have a slow onset of action and a high incidence of adverse reactions.<sup><a href="#zoi250921r8" class="usa-link" aria-describedby="zoi250921r8">8</a>,<a href="#zoi250921r9" class="usa-link" aria-describedby="zoi250921r9">9</a></sup> The SNRIs may outperform SSRIs in efficacy and speed of onset, with fewer cardiovascular complications compared with tricyclic antidepressants and monoamine oxidase inhibitors.<sup><a href="#zoi250921r10" class="usa-link" aria-describedby="zoi250921r10">10</a>,<a href="#zoi250921r11" class="usa-link" aria-describedby="zoi250921r11">11</a>,<a href="#zoi250921r12" class="usa-link" aria-describedby="zoi250921r12">12</a></sup> Furthermore, SNRIs effectively alleviate depressive symptoms associated with chronic pain, making them mainstream options in clinical practice.<sup><a href="#zoi250921r13" class="usa-link" aria-describedby="zoi250921r13">13</a></sup> Compared with SSRIs, the variety of SNRIs is limited, with duloxetine dominating the market.<sup><a href="#zoi250921r14" class="usa-link" aria-describedby="zoi250921r14">14</a></sup> While it blocks serotonin and norepinephrine transporters more potently than venlafaxine,<sup><a href="#zoi250921r15" class="usa-link" aria-describedby="zoi250921r15">15</a></sup> many patients with MDD still experience common adverse effects, such as nausea, drowsiness, dry mouth, sweating, constipation, and decreased appetite. Moreover, duloxetine may have higher hepatotoxicity than other SNRIs, such as venlafaxine,<sup><a href="#zoi250921r16" class="usa-link" aria-describedby="zoi250921r16">16</a>,<a href="#zoi250921r17" class="usa-link" aria-describedby="zoi250921r17">17</a></sup> because of its naphthyl ring, which induces oxidative stress and mitochondrial dysfunction in hepatic organoids.<sup><a href="#zoi250921r18" class="usa-link" aria-describedby="zoi250921r18">18</a></sup> Therefore, considering the burden of MDD and the potential of SNRIs, there is a need for new compounds within this class.</p>
<p>Ammoxetine, a novel SNRI developed from duloxetine,<sup><a href="#zoi250921r19" class="usa-link" aria-describedby="zoi250921r19">19</a></sup> addresses hepatotoxicity through structural modification by replacing the naphthyl ring with benzodioxole, which significantly reduces hepatotoxic effects.<sup><a href="#zoi250921r20" class="usa-link" aria-describedby="zoi250921r20">20</a></sup> Additionally, in vitro, ammoxetine exhibits a threefold to 10-fold greater potency than duloxetine in inhibiting serotonin and norepinephrine transporters.<sup><a href="#zoi250921r21" class="usa-link" aria-describedby="zoi250921r21">21</a></sup> In vivo, ammoxetine has shown stronger antidepressant effects in animal models with lower neuronal and hepatocyte toxicity.<sup><a href="#zoi250921r21" class="usa-link" aria-describedby="zoi250921r21">21</a>,<a href="#zoi250921r22" class="usa-link" aria-describedby="zoi250921r22">22</a>,<a href="#zoi250921r23" class="usa-link" aria-describedby="zoi250921r23">23</a></sup> Two phase 1 trials<sup><a href="#zoi250921r24" class="usa-link" aria-describedby="zoi250921r24">24</a>,<a href="#zoi250921r25" class="usa-link" aria-describedby="zoi250921r25">25</a></sup> in healthy volunteers demonstrated that all adverse events were mild and self-resolving, including nausea, dizziness, palpitations, and dry mouth, with no liver-related adverse event noted.<sup><a href="#zoi250921r26" class="usa-link" aria-describedby="zoi250921r26">26</a></sup> Furthermore, a high-throughput assay showed that ammoxetine weakly inhibits CYP2D6 and CYP1A2, with minimal effects on other CYP enzymes, indicating low drug interaction risk.<sup><a href="#zoi250921r20" class="usa-link" aria-describedby="zoi250921r20">20</a></sup> Based on these findings, ammoxetine has been approved for this clinical trial to evaluate its efficacy and safety in patients with MDD.</p></section><section id="H1-2-ZOI250921"><h2 class="pmc_sec_title">Methods</h2>
<section id="H2-1-ZOI250921"><h3 class="pmc_sec_title">Study Design</h3>
<p>This randomized clinical trial was a phase 2, multicenter (15 sites in China), double-masked, placebo-controlled, parallel-group study. The study was conducted in accordance with International Council for Harmonization Good Clinical Practice principles and the Declaration of Helsinki.<sup><a href="#zoi250921r27" class="usa-link" aria-describedby="zoi250921r27">27</a></sup> All participants provided written informed consent prior to enrollment, and ethical approval was obtained from local research ethics committees. The trial protocol is provided in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 1</a>. This study was reported in accordance with the Consolidated Standards of Reporting Trials (<a href="https://www.equator-network.org/reporting-guidelines/consort/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CONSORT</a>).</p>
<p>The trial included a screening period of 6 to 14 days (with a single-masked placebo run-in period of 5-7 days), an 8-week double-masked treatment period (1 week for titration and 7 weeks for dose maintenance), a 1-week double-masked dose reduction, and a 1-week safety follow-up. After signing the informed consent form, participants received placebo for 5 to 7 consecutive days. Participants were assigned in a 1:1:1 ratio using stratified blocked randomization to either the ammoxetine 40 mg/d group, the ammoxetine 60 mg/d group, or the placebo group via an interactive web response system. Stratified factors included baseline severity (Montgomery-Åsberg Depression Rating Scale [MADRS] score &gt;30 or 26-30, indicating moderate to severe depression) and patient diagnostic type (single vs recurrent episode).</p></section><section id="H2-2-ZOI250921"><h3 class="pmc_sec_title">Participants</h3>
<p>Participants aged 18 to 65 years with MDD based on <em>Diagnostic and Statistical Manual of Mental Disorders</em> (Fifth Edition) criteria<sup><a href="#zoi250921r28" class="usa-link" aria-describedby="zoi250921r28">28</a></sup> were recruited between March 27, 2023, and June 13, 2024. Inclusion criteria included a total score of 26 or higher on the MADRS, a Clinical Global Impressions–Severity (CGI-S) score of 4 or higher, and a Hamilton Rating Scale for Depression (HAMD) score of 2 or higher on the first item at screening visits. Key exclusion criteria included a reduction rate of MADRS score of 25% or greater at baseline compared with the screening period; meeting <em>Diagnostic and Statistical Manual of Mental Disorders</em> (Fifth Edition) criteria for other psychiatric disorders; depressive disorder secondary to other mental illnesses or physical conditions; and receipt of electroconvulsive therapy, systematic psychotherapy, transcranial magnetic stimulation, vagus nerve stimulation, or phototherapy within 3 months prior to screening. The full inclusion and exclusion criteria are listed in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 1</a>.</p></section><section id="H2-3-ZOI250921"><h3 class="pmc_sec_title">Procedures and Outcomes</h3>
<p>The study medication included ammoxetine tablets (40 mg and 60 mg) and placebo tablets, all identical in appearance. Participants took the medication every morning at a fixed time (1 hour plus or minus 30 minutes) after meals and recorded both medication and meal times. The specific medication plan is detailed in eTable 1 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>. During the treatment period, outcome indicators were collected at each visit.</p>
<p>The primary efficacy end point was the change in MADRS total score from baseline to week 8. Secondary efficacy end points included changes from baseline in scores measured at the end of week 8 or at each visit, including MADRS; 17-Item HAMD (HAMD-17) total score; CGI-S score; CGI-Improvement (CGI-I) score; Hamilton Anxiety Rating Scale (HAMA) total score; response rates in MADRS and HAMD-17 (≥50% decrease); remission rates in MADRS (≤10) and HAMD-17 (≤7); and the percentage of participants achieving an MADRS score reduction of 25% or more at weeks 1 and 2. Safety assessments included adverse events, withdrawal due to adverse events, vital signs, weight, physical examination, laboratory tests, 12-lead electrocardiography, the Columbia Suicide Severity Rating Scale, the Arizona Sexual Experience Scale, and the proportion of participants receiving combined hypnotic drugs.</p></section><section id="H2-4-ZOI250921"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Efficacy analyses were performed on both the full-analysis set and the per-protocol set. Safety data analysis was based on the safety set. The final analysis compared the 2 treatment groups with the placebo group. Dunnett method was used to correct for type I errors, with the primary end point tested at a 1-sided α = .01; success was achieved when at least 1 experimental group outperformed the placebo.</p>
<p>The primary end point was analyzed using analysis of covariance. The model included baseline MADRS score as a covariate, with treatment group (ammoxetine 40 mg/d, ammoxetine 60 mg/d, or placebo) and diagnosis type (a single episode of MDD or recurrent MDD) as fixed effects. Least-squares (LS) mean differences (compared with placebo), SEs, and corresponding 95% CIs or 97.3% CIs were estimated for the change from baseline at week 8.</p>
<p>Detailed methodologies for missing data imputation, sensitivity analyses, subgroup analyses, secondary end point analyses, and sample size calculations are provided in the eMethods in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>. Descriptive statistics were used to summarize demographic and safety data. All analyses were performed using SAS, version 9.4 (SAS Institute Inc).</p></section></section><section id="H1-3-ZOI250921"><h2 class="pmc_sec_title">Results</h2>
<p>A total of 290 patients were screened, and 239 (mean [SD] age, 30.4 [10.0] years; 158 female [66.1%] and 81 male [33.9%]) were randomized and received therapy, with 80 in the ammoxetine 60 mg/d group, 80 in the ammoxetine 40 mg/d group, and 79 in the placebo group (<a href="#zoi250921f1" class="usa-link">Figure 1</a>). These patients were included in both the full-analysis set for efficacy evaluation and the safety set for safety analysis. Demographics, clinical characteristics, and baseline MADRS scores were similar among groups (<a href="#zoi250921t1" class="usa-link">Table 1</a>). Eighteen participants (7.5%) with missing week 8 MADRS scores were excluded from the per-protocol set, resulting in a final per-protocol set of 221 patients (92.5%) (<a href="#zoi250921f1" class="usa-link">Figure 1</a>).</p>
<figure class="fig xbox font-sm" id="zoi250921f1"><h3 class="obj_head">Figure 1.  Flow Diagram for the Ammoxetine 60 mg/d and 40 mg/d Treatment and Placebo Groups.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12455369_jamanetwopen-e2532650-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd6/12455369/751bb0282325/jamanetwopen-e2532650-g001.jpg" loading="lazy" height="477" width="780" alt="Figure 1. "></a></p>
<div class="p text-right font-secondary"><a href="figure/zoi250921f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>FAS indicates full-analysis set; MADRS, Montgomery-Åsberg Depression Rating Scale; PPS, per-protocol set; SS, safety set.</p></figcaption></figure><section class="tw xbox font-sm" id="zoi250921t1"><h3 class="obj_head">Table 1.  Demographic and Baseline Characteristics (Full-Analysis Set).</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="39.61%" span="1">
<col width="20.13%" span="1">
<col width="20.13%" span="1">
<col width="20.13%" span="1">
<thead>
<tr>
<th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">Characteristic</th>
<th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Mean (SD)</th>
</tr>
<tr>
<th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Ammoxetine 60 mg/d group (n = 80)</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Ammoxetine 40 mg/d group (n = 80)</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Placebo group (n = 79)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y</td>
<td valign="top" align="left" rowspan="1" colspan="1">30.4 (10.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">31.6 (10.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">29.3 (9.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex, No. (%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td>
<td valign="top" align="left" rowspan="1" colspan="1">50 (62.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">56 (70.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">52 (65.8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td>
<td valign="top" align="left" rowspan="1" colspan="1">30 (37.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">24 (30.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">27 (34.2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Height, cm</td>
<td valign="top" align="left" rowspan="1" colspan="1">165.3 (8.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">164.9 (8.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">165.0 (8.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Weight, kg</td>
<td valign="top" align="left" rowspan="1" colspan="1">62.1 (11.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">63.8 (14.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">62.6 (14.4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">BMI</td>
<td valign="top" align="left" rowspan="1" colspan="1">22.7 (4.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">23.4 (4.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">22.8 (4.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<em>DSM-5</em> MDD, No. (%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">80 (100)</td>
<td valign="top" align="left" rowspan="1" colspan="1">80 (100)</td>
<td valign="top" align="left" rowspan="1" colspan="1">79 (100)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Classification of MDD episode based on <em>DSM-5</em>, No. (%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Single</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (10.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (8.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recurrent</td>
<td valign="top" align="left" rowspan="1" colspan="1">72 (90.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">73 (91.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">73 (92.4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total course of MDD, mo</td>
<td valign="top" align="left" rowspan="1" colspan="1">55.7 (50.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">71.1 (58.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">58.14 (40.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Duration of current episode, mo</td>
<td valign="top" align="left" rowspan="1" colspan="1">7.5 (10.4)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8.9 (11.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5.9 (8.7)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">MADRS total score<a href="#zoi250921t1n1" class="usa-link"><sup>a</sup></a>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">32.6 (4.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">31.9 (3.6)</td>
<td valign="top" align="left" rowspan="1" colspan="1">31.8 (3.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 26-30</td>
<td valign="top" align="left" rowspan="1" colspan="1">29 (36.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">30 (37.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">31(39.2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 30</td>
<td valign="top" align="left" rowspan="1" colspan="1">51 (63.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">50 (62.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">48 (60.8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">HAMD-17 total score</td>
<td valign="top" align="left" rowspan="1" colspan="1">21.9 (4.4)</td>
<td valign="top" align="left" rowspan="1" colspan="1">21.8 (3.6)</td>
<td valign="top" align="left" rowspan="1" colspan="1">22.0 (4.2)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">HAMA total score</td>
<td valign="top" align="left" rowspan="1" colspan="1">18.8 (5.4)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19.2 (5.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19.6 (5.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">CGI-S total score</td>
<td valign="top" align="left" rowspan="1" colspan="1">4.9 (0.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4.8 (0.6)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4.8 (0.7)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/zoi250921t1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="_fn_p41"><p>Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CGI-S, Clinical Global Impression–Severity of Illness; <em>DSM-5</em>, <em>Diagnostic and Statistical Manual of Mental Disorders</em> (Fifth Edition); HAMA, Hamilton Anxiety Rating Scale; HAMD-17, 17-Item Hamilton Rating Scale for Depression; MADRS, Montgomery-Åsberg Depression Rating Scale; MDD, major depressive disorder.</p></div>
<div class="fn" id="zoi250921t1n1">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Scores indicate moderate to severe depression.</p>
</div>
</div></section><section id="H2-5-ZOI250921"><h3 class="pmc_sec_title">Primary End Point: MADRS at Week 8</h3>
<p>After 8 weeks of treatment, both dosages of ammoxetine demonstrated statistically significant superiority over placebo in terms of the adjusted mean changes from baseline in the MADRS total score. The LS mean change (SE) from baseline was −16.7 (1.3) for ammoxetine 40 mg/d, −16.6 (1.3) for ammoxetine 60 mg/d, and −13. 5 (1.3) for placebo. Compared with placebo, the LS mean difference (SE) was −3.1 (1.3) for the ammoxetine 60 mg/d group (97.3% CI, −6.2 to 0.0; <em>P</em> = .02) and −3.3 (1.4) for the ammoxetine 40 mg/d group (97.3% CI, −6.3 to −0.3; <em>P</em> = .02) in the full-analysis set (<a href="#zoi250921t2" class="usa-link">Table 2</a>). The MADRS score change from baseline over time is shown in <a href="#zoi250921f2" class="usa-link">Figure 2</a>. In the per-protocol set, ammoxetine also achieved significant results, with an LS mean difference (SE) of −3.2 (1.4) for the ammoxetine 60 mg/d group (97.3% CI, −6.2 to −0.2; <em>P</em> = .02) and −3.2 (1.4) for the ammoxetine 40 mg/d group (97.3% CI, −6.2 to −0.2; <em>P</em> = .02) (<a href="#zoi250921t2" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="zoi250921t2"><h4 class="obj_head">Table 2.  Changes in MADRS Score From Baseline to the End of Week 8.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="35.42%" span="1">
<col width="21.51%" span="1">
<col width="21.51%" span="1">
<col width="21.56%" span="1">
<thead>
<tr>
<th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">End point</th>
<th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Least-squares mean (97.3% CI)</th>
</tr>
<tr>
<th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Ammoxetine 60 mg/d group</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Ammoxetine 40 mg/d group</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Placebo group</th>
</tr>
</thead>
<tbody>
<tr><td colspan="4" valign="top" align="left" scope="col" rowspan="1">
<strong>Full-analysis set</strong>
</td></tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of participants</td>
<td valign="top" align="left" rowspan="1" colspan="1">80</td>
<td valign="top" align="left" rowspan="1" colspan="1">80</td>
<td valign="top" align="left" rowspan="1" colspan="1">79</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">MADRS score change</td>
<td valign="top" align="left" rowspan="1" colspan="1">−16.6 (−19.3 to −13.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−16.7 (−19.5 to −13.9)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−13.5 (−16.3 to −10.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Difference vs placebo</td>
<td valign="top" align="left" rowspan="1" colspan="1">−3.1 (−6.2 to 0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−3.3 (−6.3 to −0.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<em>P</em> value<a href="#zoi250921t2n1" class="usa-link"><sup>a</sup></a>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">.02</td>
<td valign="top" align="left" rowspan="1" colspan="1">.02</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr><td colspan="4" valign="top" align="left" scope="col" rowspan="1">
<strong>Per-protocol set</strong>
</td></tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of participants</td>
<td valign="top" align="left" rowspan="1" colspan="1">73</td>
<td valign="top" align="left" rowspan="1" colspan="1">73</td>
<td valign="top" align="left" rowspan="1" colspan="1">75</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">MADRS score change</td>
<td valign="top" align="left" rowspan="1" colspan="1">−17.5 (−20.2 to −14.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−17.5 (−20.2 to −14.7)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−14.3 (−17.1 to −11.4)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Difference vs placebo</td>
<td valign="top" align="left" rowspan="1" colspan="1">−3.2 (−6.2 to −0.2)</td>
<td valign="top" align="left" rowspan="1" colspan="1">−3.2 (−6.2 to −0.2)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<em>P</em> value<a href="#zoi250921t2n1" class="usa-link"><sup>a</sup></a>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">.02</td>
<td valign="top" align="left" rowspan="1" colspan="1">.02</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/zoi250921t2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="_fn_p44"><p>Abbreviations: MADRS, Montgomery-Åsberg Depression Rating Scale; NA, not applicable.</p></div>
<div class="fn" id="zoi250921t2n1">
<sup>
<sup>a</sup>
</sup><p class="display-inline">The intergroup statistics between the ammoxetine 60 mg/d group and the placebo group, or between the ammoxetine 40 mg/d group and the placebo group were calculated using analysis of covariance, with baseline MADRS score as the covariate and group and participant diagnosis type as fixed effects. Multiple imputation was used for missing data. The primary end point was considered significant at a 2-sided α = .03.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="zoi250921f2"><h4 class="obj_head">Figure 2.  Least-Squares Mean Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score (Full-Analysis Set).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12455369_jamanetwopen-e2532650-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd6/12455369/9e6a4dc932b9/jamanetwopen-e2532650-g002.jpg" loading="lazy" height="396" width="780" alt="Figure 2. "></a></p>
<div class="p text-right font-secondary"><a href="figure/zoi250921f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Data were analyzed using analysis of covariance, and missing data were imputed based on multiple imputation. Error bars indicate standard errors.</p></figcaption></figure></section><section id="H2-6-ZOI250921"><h3 class="pmc_sec_title">Sensitivity Analysis</h3>
<p>Based on the per-protocol set plus controlled dropout patients, the first sensitivity analysis was conducted using analysis of covariance. At the end of week 8, the LS mean difference (SE) between the ammoxetine 60 mg/d and placebo groups was −2.7 (1.4) (97.3% CI, −5.8 to 0.4; <em>P</em> = .025). The LS mean difference (SE) between the ammoxetine 40 mg/d and placebo groups was −3.0 (1.4) (97.3% CI, −6.1 to 0.1; <em>P</em> = .02) (eTable 2 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>).</p>
<p>The second sensitivity analysis was conducted using a mixed-effects model with repeated measures on both the full-analysis and per-protocol sets. In the full-analysis set at week 8, the ammoxetine 60 mg/d group vs placebo demonstrated an LS mean difference (SE) of −3.5 (1.4) (97.3% CI, −6.6 to −0.4; <em>P</em> = .01), while that of the ammoxetine 40 mg/d group was −3.4 (1.4) (97.3% CI, −6.5 to −0.3; <em>P</em> = .01) (eFigure 1A in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>). Corresponding results in the per-protocol set were −3.5 (1.4) (97.3% CI, −6.6 to −0.5; <em>P</em> = .01) for ammoxetine 60 mg/d and −3.4 (1.4) (97.3% CI, −6.4 to −0.4; <em>P</em> = .01) for ammoxetine 40 mg/d (eFigure 1B in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>). Both active doses showed statistically significant superiority over placebo in both analysis sets at week 8, with results consistent with the primary analysis, thereby confirming the robustness of the treatment effect.</p></section><section id="H2-7-ZOI250921"><h3 class="pmc_sec_title">Subgroup Analysis</h3>
<p>Prespecified subgroup analyses showed that among participants with baseline MADRS scores greater than 30, the LS mean (SE) from baseline to week 8 of treatment was −17.2 (1.6) points for the ammoxetine 60 mg/d group, −19.5 (1.7) points for the ammoxetine 40 mg/d group, and −13.8 (1.7) points for the placebo group. Among these differences, the ammoxetine 40 mg/d group was significantly superior to the placebo group (2-sided <em>P</em> = .002) (eFigure 2 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>). Additionally, in participants with recurrent MDD, the LS mean (SE) in MADRS scores from baseline to week 8 of treatment was −16.3 (1.0) points for the ammoxetine 60 mg/d group, −16.1 (1.0) points for the ammoxetine 40 mg/d group, and −12.9 (1.0) points for the placebo group. Both the ammoxetine 60 mg/d and 40 mg/d groups were significantly superior to the placebo group in the full-analysis set (2-sided <em>P</em> = .03) (eFigure 2 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>). The subgroup analysis results in the per-protocol set were consistent with those in the full-analysis set (eFigure 3 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>).</p></section><section id="H2-8-ZOI250921"><h3 class="pmc_sec_title">Secondary End Point</h3>
<p>Using a covariance model with baseline HAMA scores as a covariate and group and random stratification factors as fixed effects, the change from baseline to week 8 in HAMA scores for the ammoxetine 40 mg/d group was significantly greater than that of the placebo group, with an LS mean difference (SE) of −1.8 (0.9) (95% CI, −3.4 to −0.1; <em>P</em> = .04) (eFigure 4 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>) indicating effective alleviation of anxiety symptoms. At the end of week 8, no significant differences were observed between the placebo group and the ammoxetine 60 mg/d and 40 mg/d groups using the HAMD-17, CGI-S, and CGI-I assessments; response and remission rates of MADRS; and the proportion of patients with an MADRS score reduction of 25% or more at weeks 1 or 2 (eTable 3 in <a href="#note-ZOI250921-1-s" class="usa-link">Supplement 2</a>).</p></section><section id="H2-9-ZOI250921"><h3 class="pmc_sec_title">Safety</h3>
<p>Treatment-emergent adverse events (TEAEs) were reported by 68 participants (85.0%) in the ammoxetine 60 mg/d group, 63 (78.8%) in the ammoxetine 40 mg/d group, and 48 (60.8%) in the placebo group. Most TEAEs were mild or moderate. The most common TEAEs reported for ammoxetine included dry mouth, nausea, and dizziness (<a href="#zoi250921t3" class="usa-link">Table 3</a>). The TEAEs in the experimental groups with an incidence twice as high as the placebo group were constipation, parageusia, weight loss, hyperhidrosis, decreased appetite, dry mouth, diarrhea, dizziness, and nausea. Alanine aminotransferase and aspartate aminotransferase increases in only 2 participants and 1 case of liver function abnormality occurred in the ammoxetine 60 mg/d group, and all were mild or moderate. Severe TEAEs occurred in 2 participants in the ammoxetine 60 mg/d group (1 acne, 1 constipation) and 1 in the ammoxetine 40 mg/d group (constipation) vs 0 in the placebo group.</p>
<section class="tw xbox font-sm" id="zoi250921t3"><h4 class="obj_head">Table 3.  Treatment-Emergent Adverse Events With an Incidence Rate Greater Than 5% in Any Treatment Group (Safety Set).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="34.39%" span="1">
<col width="21.87%" span="1">
<col width="21.87%" span="1">
<col width="21.87%" span="1">
<thead>
<tr>
<th rowspan="2" valign="top" align="left" scope="rowgroup" colspan="1">System organ class</th>
<th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Participants, No. (%)</th>
</tr>
<tr>
<th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Ammoxetine 60 mg/d group (n = 80)</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Ammoxetine 40 mg/d group (n = 80)</th>
<th valign="top" align="left" scope="col" rowspan="1" colspan="1">Placebo group (n = 79)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Gastrointestinal disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">38 (47.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">33 (41.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19 (24.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Nausea</td>
<td valign="top" align="left" rowspan="1" colspan="1">15 (18.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (12.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dry mouth</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (17.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (12.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (5.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Constipation</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (10.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (10.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Diarrhea</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (2.5)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Investigations<a href="#zoi250921t3n1" class="usa-link"><sup>a</sup></a>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">27 (33.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">17 (21.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">18 (22.8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Weight loss</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (12.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (1.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Nervous system disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">22 (27.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">22 (27.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">11 (13.9)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dizziness</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (17.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (5.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Headache</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (5.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">12 (15.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Parageusia</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (3.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Infections and infestations</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">9 (11.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (17.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">13 (16.5)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Upper respiratory tract infection</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (10.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Nasopharyngitis</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (3.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (3.8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Metabolism and nutrition disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (12.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">13 (16.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.6)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Decreased appetite</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (8.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (2.5)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Psychiatric disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">13 (16.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (5.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Insomnia</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (7.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (2.5)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (3.8)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Cardiac disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">11 (13.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (8.9)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Palpitations</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (6.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (10.0)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (5.1)</td>
</tr>
<tr>
<td valign="top" align="left" scope="col" rowspan="1" colspan="1">Skin and subcutaneous tissue disorders</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Any</td>
<td valign="top" align="left" rowspan="1" colspan="1">11 (13.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (3.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (1.3)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hyperhidrosis</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (8.8)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (1.3)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (1.3)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/zoi250921t3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="zoi250921t3n1">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Among the treatment-emergent adverse events with an incidence of greater than 5% across various investigations, weight loss was the only one that exceeded the threshold.</p>
</div></div></section><p>In the ammoxetine 60 mg/d group, 1 drug-related serious adverse event that was moderate in severity (depressive symptoms and suicidal behavior) occurred. The participant recovered but discontinued treatment and withdrew from the trial. No serious adverse events in the ammoxetine 40 mg/d or placebo groups occurred, and there were no deaths.</p>
<p>The number of participants with suicidal thoughts at baseline were 12 (15.0%), 6 (7.5%), and 11 (13.9%) in the ammoxetine 60 mg/d, ammoxetine 40 mg/d, and placebo groups, respectively. At 8 weeks of treatment, the numbers were 4 (5.5%), 3 (4.1%), and 2 (2.7%), respectively. At baseline, there was 1 participant each in the ammoxetine 40 mg/d and placebo groups who exhibited suicidal behavior; at 4 weeks of treatment, 1 participant each in the ammoxetine 60 mg/d and 40 mg/d groups exhibited suicidal behavior. These participants did not exhibit suicidal behavior at the remaining visits. The TEAEs that led to withdrawal from the trial included 3 participants (3.8%) in the ammoxetine 60 mg/d group (euphoria, suicidal behavior, vomiting), 2 (2.5%) in the ammoxetine 40 mg/d group (suicidal thoughts, nausea), and 1 (1.3%) in the placebo group (suicidal thoughts).</p>
<p>After the 8-week treatment, LS mean differences (SEs) from baseline in male participants’ Arizona Sexual Experience Scale total scores were 0.1 (3.8) points in the ammoxetine 60 mg/d group, −0.5 (3.7) points in the ammoxetine 40 mg/d group, and −0.7 (2.5) points in the placebo group. In female participants, the differences were −1.8 (3.5), −1.8 (3.9), and −0.6 (3.0), respectively. Ammoxetine enhanced female participants’ sexual experience to a greater extent. No clinically significant changes in vital signs, laboratory tests, or electrocardiography results were observed. Both ammoxetine doses demonstrated weight reduction (<a href="#zoi250921t3" class="usa-link">Table 3</a>).</p></section></section><section id="H1-4-ZOI250921"><h2 class="pmc_sec_title">Discussion</h2>
<p>This phase 2 randomized clinical trial evaluated the efficacy and safety of ammoxetine in patients with MDD. After 8 weeks of treatment, both the 40 mg/d and 60 mg/d doses of ammoxetine significantly improved depressive symptoms compared with placebo, as indicated by analyses from both the full-analysis and per-protocol sets. In both analytic sets, the mean treatment differences for the ammoxetine 40 mg/d and 60 mg/d groups exceeded 3, which is considered clinically significant.<sup><a href="#zoi250921r29" class="usa-link" aria-describedby="zoi250921r29">29</a>,<a href="#zoi250921r30" class="usa-link" aria-describedby="zoi250921r30">30</a></sup> These consistent results enhanced our confidence in the trial outcomes.</p>
<p>Additionally, we conducted 2 sensitivity analyses to verify the robustness and consistency of the primary efficacy results. The first sensitivity analysis was based on the per-protocol set while accounting for controlled dropout patients. At week 8, both doses of ammoxetine demonstrated improvements in depressive symptoms compared with placebo. Although neither group showed statistical significance, which may have been due to the conservativeness of this analysis, these results are still notable. The second sensitivity analysis confirmed significant differences at week 8 between both the ammoxetine 40 mg/d and 60 mg/d groups and the placebo group. Thus, conclusions drawn from both datasets were consistent, enhancing our confidence in the efficacy of ammoxetine.</p>
<p>In the subgroup analysis based on the full-analysis set, participants with baseline MADRS scores greater than 30 exhibited superior efficacy of ammoxetine 40 mg/d compared with placebo at the end of the 8-week treatment period. However, no significant differences were observed for either dose of ammoxetine in participants with MADRS scores between 26 and 30. For participants with recurrent MDD, both the ammoxetine 60 mg/d and 40 mg/d groups demonstrated statistically significant superiority over placebo. In contrast, neither ammoxetine group showed significant superiority over placebo in participants with a first episode of MDD, possibly due to a stronger placebo effect in these patients. These findings suggest that ammoxetine has a pronounced effect in treating recurrent depressive disorder, consistent with the per-protocol results.</p>
<p>The LS mean differences in MADRS scores from baseline to 8 weeks were 16.6 for the ammoxetine 60 mg/d group, 16.7 for the ammoxetine 40 mg/d group, and 13.5 for the placebo group. The improvement seen with ammoxetine was comparable to that reported in studies of duloxetine, vortioxetine, and vilazodone. Previous trials indicated LS mean changes of 14.3 for vortioxetine 15 mg/d, 15.6 for vortioxetine 20 mg/d, 16.9 for duloxetine 60 mg/d, and 13.3 for vilazodone 40 mg/d.<sup><a href="#zoi250921r31" class="usa-link" aria-describedby="zoi250921r31">31</a>,<a href="#zoi250921r32" class="usa-link" aria-describedby="zoi250921r32">32</a></sup></p>
<p>The rate of TEAEs was 85.0% in the ammoxetine 60 mg/d group and 78.8% in the ammoxetine 40 mg/d group. These rates align with a meta-analysis reporting TEAE rates of 73.3% to 73.6% for escitalopram and 78.2% for other SSRIs,<sup><a href="#zoi250921r33" class="usa-link" aria-describedby="zoi250921r33">33</a></sup> alongside 77.4% for SNRIs (including venlafaxine and duloxetine).<sup><a href="#zoi250921r29" class="usa-link" aria-describedby="zoi250921r29">29</a></sup></p>
<p>In terms of discontinuation rates due to treatment-related adverse events, ammoxetine exhibited lower rates compared with other antidepressant drugs. Specifically, ammoxetine had discontinuation rates of 3.8% in in 60 mg/d group and 2.5% in the 40 mg/d group, which are lower than the average rate of 7% found in a comprehensive meta-analysis of antidepressant trials.<sup><a href="#zoi250921r34" class="usa-link" aria-describedby="zoi250921r34">34</a></sup> Conversely, duloxetine and venlafaxine had higher discontinuation rates of approximately 9% and 12%, respectively.<sup><a href="#zoi250921r35" class="usa-link" aria-describedby="zoi250921r35">35</a>,<a href="#zoi250921r36" class="usa-link" aria-describedby="zoi250921r36">36</a></sup> Compared with recently developed antidepressant drugs, vortioxetine showed rates ranging from 5% to 8% across different doses.<sup><a href="#zoi250921r37" class="usa-link" aria-describedby="zoi250921r37">37</a></sup> As for ansofaxine, the discontinuation rates due to treatment-related adverse events were 3.8% and 7.1% at doses of 80 mg/d and 160 mg/d, respectively.<sup><a href="#zoi250921r29" class="usa-link" aria-describedby="zoi250921r29">29</a></sup></p>
<p>In this study, the incidence of liver function abnormalities in the ammoxetine groups was 0.6%, with no patients discontinuing treatment due to these issues. Previous studies on duloxetine showed that alanine aminotransferase elevations greater than 3 times the upper limit of normal occurred in 1.4% of patients, and 0.3% discontinued treatment due to liver transaminase elevations.<sup><a href="#zoi250921r34" class="usa-link" aria-describedby="zoi250921r34">34</a></sup> These findings suggest that ammoxetine has a lower risk of liver safety issues compared with duloxetine. Overall, the data indicate that ammoxetine demonstrates a comparable or potentially superior safety and tolerability profile relative to commonly used antidepressants.</p>
<p>The most common TEAEs reported for ammoxetine were dry mouth, nausea, and dizziness, similar to patterns observed with SSRIs and SNRIs.<sup><a href="#zoi250921r33" class="usa-link" aria-describedby="zoi250921r33">33</a>,<a href="#zoi250921r38" class="usa-link" aria-describedby="zoi250921r38">38</a></sup> Sexual dysfunction, a frequent adverse effect of serotonin reuptake inhibitors, is a common reason for discontinuation. Notably, no patients discontinued treatment due to sexual dysfunction, suggesting that ammoxetine is safe and well tolerated.</p>
<section id="H2-10-ZOI250921"><h3 class="pmc_sec_title">Limitations</h3>
<p>This study had some limitations. An important limitation was the small sample size, which highlights the need for further research with a larger cohort. Additionally, the exclusion of patients with comorbid conditions may have limited the generalizability of the results to typical clinical practice. Moreover, as a phase 2 proof-of-concept study, it was not designed or powered for formal dose comparisons between ammoxetine 40 mg/d and 60 mg/d; therefore, a dedicated phase 3 trial has been designed to determine the optimal dose that balances efficacy and safety.<sup><a href="#zoi250921r39" class="usa-link" aria-describedby="zoi250921r39">39</a></sup> Finally, the absence of an active comparator group limited direct comparisons with existing antidepressant treatments.</p></section></section><section id="H1-5-ZOI250921"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This randomized clinical trial demonstrates the efficacy, safety, and tolerability of ammoxetine in patients with MDD. These results support the need for further phase 3 trial investigations, which should involve larger samples.</p></section><section id="note-ZOI250921-1"><section class="sm xbox font-sm" id="note-ZOI250921-1-s"><div class="caption p">
<span>Supplement 1.</span><p>
Trial Protocol
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s001.pdf</a><sup> (1.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="supplementary-material2"><div class="caption p">
<span>Supplement 2.</span><p>
eMethods.
</p>
<p><strong>eTable 1.</strong> Dosage and Medication Plan</p>
<p><strong>eTable 2.</strong> Sensitivity Analysis 1: Changes in MADRS Score From Baseline to the End of Week 8 (PPS + Controlled Dropout Participants)</p>
<p><strong>eTable 3.</strong> Changes of Secondary End Points From Baseline to Week 8 in FAS</p>
<p><strong>eFigure 1.</strong> Sensitivity Analysis 2</p>
<p><strong>eFigure 2.</strong> Forest Plot of Subgroup Analyses Based on Full-Analysis Set</p>
<p><strong>eFigure 3.</strong> Subgroup Analyses Based on Per-Protocol Set</p>
<p><strong>eFigure 4.</strong> Least-Squares Mean Change From Baseline in HAMA Score (Full-Analysis Set)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s002.pdf</a><sup> (702.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="supplementary-material3"><div class="caption p">
<span>Supplement 3.</span><p>
Data Sharing Statement
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s003.pdf</a><sup> (17.7KB, pdf) </sup>
</div></div></section></section><section id="REF-ZOI250921" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="REF-ZOI250921_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="zoi250921r1">
<span class="label">1.</span><cite>World Health Organization . Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization; 2017.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Depression%20and%20Other%20Common%20Mental%20Disorders:%20Global%20Health%20Estimates&amp;publication_year=2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r2">
<span class="label">2.</span><cite>Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the preventable burden of NCD. Glob Heart. 2016;11(4):393-397. doi: 10.1016/j.gheart.2016.10.024
</cite> [<a href="https://doi.org/10.1016/j.gheart.2016.10.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27938824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glob%20Heart&amp;title=The%20Global%20Burden%20of%20Disease%20Study%20and%20the%20preventable%20burden%20of%20NCD&amp;volume=11&amp;issue=4&amp;publication_year=2016&amp;pages=393-397&amp;pmid=27938824&amp;doi=10.1016/j.gheart.2016.10.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r3">
<span class="label">3.</span><cite>Mental health and development. United Nations Department of Economic and Social Affairs. Accessed December 20, 2024. <a href="https://www.un.org/development/desa/disabilities/issues/mental-health-and-development.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.un.org/development/desa/disabilities/issues/mental-health-and-development.html</a></cite>
</li>
<li id="zoi250921r4">
<span class="label">4.</span><cite>Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212290. doi: 10.7573/dic.212290
</cite> [<a href="https://doi.org/10.7573/dic.212290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4630974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26576188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs%20Context&amp;title=Antidepressant%20efficacy%20and%20side-effect%20burden:%20a%20quick%20guide%20for%20clinicians&amp;volume=4&amp;publication_year=2015&amp;pages=212290&amp;pmid=26576188&amp;doi=10.7573/dic.212290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r5">
<span class="label">5.</span><cite>Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9(1):30. doi: 10.1038/s41392-024-01738-y
</cite> [<a href="https://doi.org/10.1038/s41392-024-01738-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10853571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38331979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Target%20Ther&amp;title=Major%20depressive%20disorder:%20hypothesis,%20mechanism,%20prevention%20and%20treatment&amp;volume=9&amp;issue=1&amp;publication_year=2024&amp;pages=30&amp;pmid=38331979&amp;doi=10.1038/s41392-024-01738-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r6">
<span class="label">6.</span><cite>Zaidi A, Shami R, Sewell IJ, et al. Antidepressant class and concurrent rTMS outcomes in major depressive disorder: a systematic review and meta-analysis. EClinicalMedicine. 2024;75:102760. doi: 10.1016/j.eclinm.2024.102760
</cite> [<a href="https://doi.org/10.1016/j.eclinm.2024.102760" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11338161/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39170936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&amp;title=Antidepressant%20class%20and%20concurrent%20rTMS%20outcomes%20in%20major%20depressive%20disorder:%20a%20systematic%20review%20and%20meta-analysis&amp;volume=75&amp;publication_year=2024&amp;pages=102760&amp;pmid=39170936&amp;doi=10.1016/j.eclinm.2024.102760&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r7">
<span class="label">7.</span><cite>Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. doi: 10.1176/ajp.2006.163.11.1905
</cite> [<a href="https://doi.org/10.1176/ajp.2006.163.11.1905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17074942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Psychiatry&amp;title=Acute%20and%20longer-term%20outcomes%20in%20depressed%20outpatients%20requiring%20one%20or%20several%20treatment%20steps:%20a%20STAR*D%20report&amp;volume=163&amp;issue=11&amp;publication_year=2006&amp;pages=1905-1917&amp;pmid=17074942&amp;doi=10.1176/ajp.2006.163.11.1905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r8">
<span class="label">8.</span><cite>Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? a cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009;195(2):102-108. doi: 10.1192/bjp.bp.108.051193
</cite> [<a href="https://doi.org/10.1192/bjp.bp.108.051193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19648538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Psychiatry&amp;title=Why%20do%20antidepressants%20take%20so%20long%20to%20work?%20a%20cognitive%20neuropsychological%20model%20of%20antidepressant%20drug%20action&amp;volume=195&amp;issue=2&amp;publication_year=2009&amp;pages=102-108&amp;pmid=19648538&amp;doi=10.1192/bjp.bp.108.051193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r9">
<span class="label">9.</span><cite>Campos AI, Mulcahy A, Thorp JG, et al. Understanding genetic risk factors for common side effects of antidepressant medications. Commun Med (Lond). 2021;1:45. doi: 10.1038/s43856-021-00046-8
</cite> [<a href="https://doi.org/10.1038/s43856-021-00046-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9053224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35602235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun%20Med%20(Lond)&amp;title=Understanding%20genetic%20risk%20factors%20for%20common%20side%20effects%20of%20antidepressant%20medications&amp;volume=1&amp;publication_year=2021&amp;pages=45&amp;pmid=35602235&amp;doi=10.1038/s43856-021-00046-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r10">
<span class="label">10.</span><cite>Thase ME. Are SNRIs more effective than SSRIs? a review of the current state of the controversy. Psychopharmacol Bull. 2008;41(2):58-85.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18668017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacol%20Bull&amp;title=Are%20SNRIs%20more%20effective%20than%20SSRIs?%20a%20review%20of%20the%20current%20state%20of%20the%20controversy&amp;volume=41&amp;issue=2&amp;publication_year=2008&amp;pages=58-85&amp;pmid=18668017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r11">
<span class="label">11.</span><cite>Li J, Lu C, Gao Z, et al. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain. Neuropharmacology. 2020;177:108237. doi: 10.1016/j.neuropharm.2020.108237
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2020.108237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32710978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=SNRIs%20achieve%20faster%20antidepressant%20effects%20than%20SSRIs%20by%20elevating%20the%20concentrations%20of%20dopamine%20in%20the%20forebrain&amp;volume=177&amp;publication_year=2020&amp;pages=108237&amp;pmid=32710978&amp;doi=10.1016/j.neuropharm.2020.108237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r12">
<span class="label">12.</span><cite>Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Cochrane Database Syst Rev. 2015;2015(5):CD011681. doi: 10.1002/14651858.CD011681
</cite> [<a href="https://doi.org/10.1002/14651858.CD011681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6864942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25931277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Selective%20serotonin%20reuptake%20inhibitors%20(SSRIs)%20and%20serotonin-norepinephrine%20reuptake%20inhibitors%20(SNRIs)%20for%20the%20prevention%20of%20tension-type%20headache%20in%20adults&amp;volume=2015&amp;issue=5&amp;publication_year=2015&amp;pages=CD011681&amp;pmid=25931277&amp;doi=10.1002/14651858.CD011681&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r13">
<span class="label">13.</span><cite>Lee YC, Chen PP. A review of SSRIs and SNRIs in neuropathic pain. Expert Opin Pharmacother. 2010;11(17):2813-2825. doi: 10.1517/14656566.2010.507192
</cite> [<a href="https://doi.org/10.1517/14656566.2010.507192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20642317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Pharmacother&amp;title=A%20review%20of%20SSRIs%20and%20SNRIs%20in%20neuropathic%20pain&amp;volume=11&amp;issue=17&amp;publication_year=2010&amp;pages=2813-2825&amp;pmid=20642317&amp;doi=10.1517/14656566.2010.507192&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r14">
<span class="label">14.</span><cite>Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25(6):871-880. doi: 10.1016/S0893-133X(01)00298-6
</cite> [<a href="https://doi.org/10.1016/S0893-133X(01)00298-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11750180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Comparative%20affinity%20of%20duloxetine%20and%20venlafaxine%20for%20serotonin%20and%20norepinephrine%20transporters%20in%20vitro%20and%20in%20vivo,%20human%20serotonin%20receptor%20subtypes,%20and%20other%20neuronal%20receptors&amp;volume=25&amp;issue=6&amp;publication_year=2001&amp;pages=871-880&amp;pmid=11750180&amp;doi=10.1016/S0893-133X(01)00298-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r15">
<span class="label">15.</span><cite>Lin ND, Norman H, Regev A, et al. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. BMC Gastroenterol. 2015;15:134. doi: 10.1186/s12876-015-0373-4
</cite> [<a href="https://doi.org/10.1186/s12876-015-0373-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4607169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26467777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Gastroenterol&amp;title=Hepatic%20outcomes%20among%20adults%20taking%20duloxetine:%20a%20retrospective%20cohort%20study%20in%20a%20US%20health%20care%20claims%20database&amp;volume=15&amp;publication_year=2015&amp;pages=134&amp;pmid=26467777&amp;doi=10.1186/s12876-015-0373-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r16">
<span class="label">16.</span><cite>Yuan W, Williams B. Acute hepatic failure involving duloxetine hydrochloride. J Neuropsychiatry Clin Neurosci. 2012;24(2):E48-E49. doi: 10.1176/appi.neuropsych.11060132
</cite> [<a href="https://doi.org/10.1176/appi.neuropsych.11060132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22772703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuropsychiatry%20Clin%20Neurosci&amp;title=Acute%20hepatic%20failure%20involving%20duloxetine%20hydrochloride&amp;volume=24&amp;issue=2&amp;publication_year=2012&amp;pages=E48-E49&amp;pmid=22772703&amp;doi=10.1176/appi.neuropsych.11060132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r17">
<span class="label">17.</span><cite>Hanje AJ, Pell LJ, Votolato NA, Frankel WL, Kirkpatrick RB. Case report: fulminant hepatic failure involving duloxetine hydrochloride. Clin Gastroenterol Hepatol. 2006;4(7):912-917. doi: 10.1016/j.cgh.2006.04.018
</cite> [<a href="https://doi.org/10.1016/j.cgh.2006.04.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16797245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Gastroenterol%20Hepatol&amp;title=Case%20report:%20fulminant%20hepatic%20failure%20involving%20duloxetine%20hydrochloride&amp;volume=4&amp;issue=7&amp;publication_year=2006&amp;pages=912-917&amp;pmid=16797245&amp;doi=10.1016/j.cgh.2006.04.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r18">
<span class="label">18.</span><cite>Liu J, Li R, Zhang T, et al. High-content imaging of human hepatic spheroids for researching the mechanism of duloxetine-induced hepatotoxicity. Cell Death Dis. 2022;13(8):669. doi: 10.1038/s41419-022-05042-x
</cite> [<a href="https://doi.org/10.1038/s41419-022-05042-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9343405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35915074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=High-content%20imaging%20of%20human%20hepatic%20spheroids%20for%20researching%20the%20mechanism%20of%20duloxetine-induced%20hepatotoxicity&amp;volume=13&amp;issue=8&amp;publication_year=2022&amp;pages=669&amp;pmid=35915074&amp;doi=10.1038/s41419-022-05042-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r19">
<span class="label">19.</span><cite>Zhang YP, Xue R, He XH, Meng YG, Zhang YZ, Zhong BH. Design, synthesis and antidepressive activity of duloxetine derivatives. Article in Chinese. Yao Xue Xue Bao. 2010;45(7):869-873.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20931784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Yao%20Xue%20Xue%20Bao&amp;title=Design,%20synthesis%20and%20antidepressive%20activity%20of%20duloxetine%20derivatives&amp;volume=45&amp;issue=7&amp;publication_year=2010&amp;pages=869-873&amp;pmid=20931784&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r20">
<span class="label">20.</span><cite>Zhu X, Li Y, Luo H, Zhang Y, Zhang Z, Li J. In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor. Front Pharmacol. 2024;15:1486856. doi: 10.3389/fphar.2024.1486856
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1486856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11579541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39575392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=In%20vitro,%20in%20vivo,%20and%20in%20silico%20approaches%20for%20evaluating%20the%20preclinical%20DMPK%20profiles%20of%20ammoxetine,%20a%20novel%20chiral%20serotonin%20and%20norepinephrine%20reuptake%20inhibitor&amp;volume=15&amp;publication_year=2024&amp;pages=1486856&amp;pmid=39575392&amp;doi=10.3389/fphar.2024.1486856&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r21">
<span class="label">21.</span><cite>Xue R, Jin ZL, Chen HX, et al. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. Eur Neuropsychopharmacol. 2013;23(7):728-741. doi: 10.1016/j.euroneuro.2012.06.001
</cite> [<a href="https://doi.org/10.1016/j.euroneuro.2012.06.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22748419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Neuropsychopharmacol&amp;title=Antidepressant-like%20effects%20of%20071031B,%20a%20novel%20serotonin%20and%20norepinephrine%20reuptake%20inhibitor&amp;volume=23&amp;issue=7&amp;publication_year=2013&amp;pages=728-741&amp;pmid=22748419&amp;doi=10.1016/j.euroneuro.2012.06.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r22">
<span class="label">22.</span><cite>Xue R, Zhang YP, Jin ZL, et al. The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor. Neurosci Lett. 2013;544:68-73. doi: 10.1016/j.neulet.2013.02.076
</cite> [<a href="https://doi.org/10.1016/j.neulet.2013.02.076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23570736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosci%20Lett&amp;title=The%20discovery%20of%20071031B,%20a%20novel%20serotonin%20and%20noradrenaline%20reuptake%20inhibitor&amp;volume=544&amp;publication_year=2013&amp;pages=68-73&amp;pmid=23570736&amp;doi=10.1016/j.neulet.2013.02.076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r23">
<span class="label">23.</span><cite>Xue R, He XH, Yuan L, et al. Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats. J Pharmacol Sci. 2016;130(1):1-7. doi: 10.1016/j.jphs.2015.07.043
</cite> [<a href="https://doi.org/10.1016/j.jphs.2015.07.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26318675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharmacol%20Sci&amp;title=Effects%20of%20071031B,%20a%20novel%20serotonin%20and%20norepinephrine%20reuptake%20inhibitor,%20on%20monoamine%20system%20in%20mice%20and%20rats&amp;volume=130&amp;issue=1&amp;publication_year=2016&amp;pages=1-7&amp;pmid=26318675&amp;doi=10.1016/j.jphs.2015.07.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r24">
<span class="label">24.</span><cite>Study of ammoxetine hydrochloride enteric-coated tablets in healthy subjects. ClinicalTrials.gov identifier: <a href="https://clinicaltrials.gov/ct2/show/NCT03456388" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03456388</a>. Updated February 20, 2019. Accessed November 24, 2024. <a href="https://clinicaltrials.gov/study/NCT03456388" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT03456388</a></cite>
</li>
<li id="zoi250921r25">
<span class="label">25.</span><cite>Study of ammoxetine hydrochloride enteric-coated tablets in healthy subject. ClinicalTrials.gov identifier: <a href="https://clinicaltrials.gov/ct2/show/NCT03850834" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03850834</a>. Updated February 20, 2019. Accessed November 24, 2024. <a href="https://clinicaltrials.gov/study/NCT03850834" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT03850834</a></cite>
</li>
<li id="zoi250921r26">
<span class="label">26.</span><cite>Shen Q, Hu C, Miao J, et al. First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study. Eur J Pharm Sci. 2021;159:105724. doi: 10.1016/j.ejps.2021.105724
</cite> [<a href="https://doi.org/10.1016/j.ejps.2021.105724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33482315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharm%20Sci&amp;title=First-in-human%20safety,%20tolerability,%20and%20pharmacokinetics%20of%20ammoxetine%20in%20healthy%20subjects:%20a%20randomized,%20double-blind,%20placebo-controlled%20phase%20I%20study&amp;volume=159&amp;publication_year=2021&amp;pages=105724&amp;pmid=33482315&amp;doi=10.1016/j.ejps.2021.105724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r27">
<span class="label">27.</span><cite>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.
JAMA. 2013;310(20):2191-2194. doi: 10.1001/jama.2013.281053
</cite> [<a href="https://doi.org/10.1001/jama.2013.281053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24141714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=World%20Medical%20Association%20Declaration%20of%20Helsinki:%20ethical%20principles%20for%20medical%20research%20involving%20human%20subjects.&amp;volume=310&amp;issue=20&amp;publication_year=2013&amp;pages=2191-2194&amp;pmid=24141714&amp;doi=10.1001/jama.2013.281053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r28">
<span class="label">28.</span><cite>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Diagnostic%20and%20Statistical%20Manual%20of%20Mental%20Disorders&amp;publication_year=2013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r29">
<span class="label">29.</span><cite>Mi W, Di X, Wang Y, et al. A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder. Transl Psychiatry. 2023;13(1):163. doi: 10.1038/s41398-023-02435-0
</cite> [<a href="https://doi.org/10.1038/s41398-023-02435-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10171157/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37164957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Psychiatry&amp;title=A%20phase%203,%20multicenter,%20double-blind,%20randomized,%20placebo-controlled%20clinical%20trial%20to%20verify%20the%20efficacy%20and%20safety%20of%20ansofaxine%20(LY03005)%20for%20major%20depressive%20disorder&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=163&amp;pmid=37164957&amp;doi=10.1038/s41398-023-02435-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r30">
<span class="label">30.</span><cite>National Institute for Health and Care Excellence . Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline CG23. National Institute for Health and Care Excellence; 2004.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Depression:%20Management%20of%20Depression%20in%20Primary%20and%20Secondary%20Care&amp;publication_year=2004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r31">
<span class="label">31.</span><cite>Mahableshwarkar AR, Jacobsen PL, Chen Y, Serenko M, Trivedi MH. A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD. Psychopharmacology (Berl). 2015;232(12):2061-2070. doi: 10.1007/s00213-014-3839-0
</cite> [<a href="https://doi.org/10.1007/s00213-014-3839-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4432084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25575488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology%20(Berl)&amp;title=A%20randomized,%20double-blind,%20duloxetine-referenced%20study%20comparing%20efficacy%20and%20tolerability%20of%202%20fixed%20doses%20of%20vortioxetine%20in%20the%20acute%20treatment%20of%20adults%20with%20MDD&amp;volume=232&amp;issue=12&amp;publication_year=2015&amp;pages=2061-2070&amp;pmid=25575488&amp;doi=10.1007/s00213-014-3839-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r32">
<span class="label">32.</span><cite>Khan A, Cutler AJ, Kajdasz DK, et al. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry. 2011;72(4):441-447. doi: 10.4088/JCP.10m06596
</cite> [<a href="https://doi.org/10.4088/JCP.10m06596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21527122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Psychiatry&amp;title=A%20randomized,%20double-blind,%20placebo-controlled,%208-week%20study%20of%20vilazodone,%20a%20serotonergic%20agent%20for%20the%20treatment%20of%20major%20depressive%20disorder&amp;volume=72&amp;issue=4&amp;publication_year=2011&amp;pages=441-447&amp;pmid=21527122&amp;doi=10.4088/JCP.10m06596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r33">
<span class="label">33.</span><cite>Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin. 2009;25(1):161-175. doi: 10.1185/03007990802622726
</cite> [<a href="https://doi.org/10.1185/03007990802622726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19210149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Res%20Opin&amp;title=Escitalopram%20in%20the%20treatment%20of%20major%20depressive%20disorder:%20a%20meta-analysis&amp;volume=25&amp;issue=1&amp;publication_year=2009&amp;pages=161-175&amp;pmid=19210149&amp;doi=10.1185/03007990802622726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r34">
<span class="label">34.</span><cite>Schalkwijk S, Undurraga J, Tondo L, Baldessarini RJ. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. Int J Neuropsychopharmacol. 2014;17(8):1343-1352. doi: 10.1017/S1461145714000224
</cite> [<a href="https://doi.org/10.1017/S1461145714000224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24621827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Neuropsychopharmacol&amp;title=Declining%20efficacy%20in%20controlled%20trials%20of%20antidepressants:%20effects%20of%20placebo%20dropout&amp;volume=17&amp;issue=8&amp;publication_year=2014&amp;pages=1343-1352&amp;pmid=24621827&amp;doi=10.1017/S1461145714000224&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r35">
<span class="label">35.</span><cite>Cymbalta prescribing information. US Food and Drug Administration. Accessed December 20, 2024. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022148lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022148lbl.pdf</a></cite>
</li>
<li id="zoi250921r36">
<span class="label">36.</span><cite>Effexor XR prescribing information. US Food and Drug Administration. Accessed December 23, 2024. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf</a></cite>
</li>
<li id="zoi250921r37">
<span class="label">37.</span><cite>Brintellix prescribing information. US Food and Drug Administration. Accessed December 23, 2024. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204447s000lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204447s000lbl.pdf</a></cite>
</li>
<li id="zoi250921r38">
<span class="label">38.</span><cite>Deardorff WJ, Grossberg GT. A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine. Expert Opin Pharmacother. 2014;15(17):2525-2542. doi: 10.1517/14656566.2014.960842
</cite> [<a href="https://doi.org/10.1517/14656566.2014.960842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25224953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Pharmacother&amp;title=A%20review%20of%20the%20clinical%20efficacy,%20safety%20and%20tolerability%20of%20the%20antidepressants%20vilazodone,%20levomilnacipran%20and%20vortioxetine&amp;volume=15&amp;issue=17&amp;publication_year=2014&amp;pages=2525-2542&amp;pmid=25224953&amp;doi=10.1517/14656566.2014.960842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="zoi250921r39">
<span class="label">39.</span><cite>The research of ammoxetine hydrochloride enteric-coated tables in subjects with depression. ClinicalTrials.gov identifier: <a href="https://clinicaltrials.gov/ct2/show/NCT06827431" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06827431</a>. Updated February 14, 2025. Accessed November 24, 2024. <a href="https://clinicaltrials.gov/study/NCT03850834" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT068274</a></cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplement 1.</span><p>
Trial Protocol
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s001.pdf</a><sup> (1.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>Supplement 2.</span><p>
eMethods.
</p>
<p><strong>eTable 1.</strong> Dosage and Medication Plan</p>
<p><strong>eTable 2.</strong> Sensitivity Analysis 1: Changes in MADRS Score From Baseline to the End of Week 8 (PPS + Controlled Dropout Participants)</p>
<p><strong>eTable 3.</strong> Changes of Secondary End Points From Baseline to Week 8 in FAS</p>
<p><strong>eFigure 1.</strong> Sensitivity Analysis 2</p>
<p><strong>eFigure 2.</strong> Forest Plot of Subgroup Analyses Based on Full-Analysis Set</p>
<p><strong>eFigure 3.</strong> Subgroup Analyses Based on Per-Protocol Set</p>
<p><strong>eFigure 4.</strong> Least-Squares Mean Change From Baseline in HAMA Score (Full-Analysis Set)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s002.pdf</a><sup> (702.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Supplement 3.</span><p>
Data Sharing Statement
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12455369/bin/jamanetwopen-e2532650-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">jamanetwopen-e2532650-s003.pdf</a><sup> (17.7KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from JAMA Network Open are provided here courtesy of <strong>American Medical Association</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1001/jamanetworkopen.2025.32650"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12455369/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12455369/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12455369%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12455369/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12455369/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12455369/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40982284/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12455369/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40982284/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12455369/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12455369/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Ks3MZaO5PzpbtROs083ECIZmTZvs2Np8316cXjZkpZ74tI2mTtsqMqoVMIR3aCA9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
